Jim Simons Jazz Pharmaceuticals PLC Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,044,574 shares of JAZZ stock, worth $118 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,044,574

Previous 1,001,874 4.26%

Holding current value

$118 Million

Previous $123 Million 5.11%

% of portfolio

0.21%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$120.07 - $144.17 $5.13 Million - $6.16 Million	42,700 Added 4.26%	1,044,574 $130 Million
Q4 2024 Feb 13, 2025	SELL	$107.32 - $127.74 $5.16 Million - $6.14 Million	-48,100 Reduced 4.58%	1,001,874 $123 Million
Q3 2024 Nov 13, 2024	BUY	$100.57 - $116.37 $2.42 Million - $2.81 Million	24,106 Added 2.35%	1,049,974 $117 Million
Q2 2024 Aug 09, 2024	SELL	$103.94 - $118.98 $14.5 Million - $16.6 Million	-139,700 Reduced 11.99%	1,025,868 $109 Million
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $7.6 Million - $8.76 Million	-66,006 Reduced 5.36%	1,165,568 $140 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $8.69 Million - $10.3 Million	-76,041 Reduced 5.82%	1,231,574 $151 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $2.14 Million - $2.54 Million	17,506 Added 1.36%	1,307,615 $169 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $4.35 Million - $5.22 Million	35,500 Added 2.83%	1,290,109 $160 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $4.74 Million - $5.68 Million	-35,406 Reduced 2.74%	1,254,609 $184 Million
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $1.1 Million - $1.36 Million	-8,494 Reduced 0.65%	1,290,015 $206 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $16.2 Million - $20.6 Million	-127,600 Reduced 8.95%	1,298,509 $173 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $12.9 Million - $15.4 Million	-91,200 Reduced 6.01%	1,426,109 $222 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $23.8 Million - $29.4 Million	-183,200 Reduced 10.77%	1,517,309 $236 Million
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $35.8 Million - $43.5 Million	-298,500 Reduced 14.93%	1,700,509 $217 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $40.9 Million - $58.8 Million	-318,231 Reduced 13.73%	1,999,009 $260 Million
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $55.3 Million - $64.4 Million	-345,410 Reduced 12.97%	2,317,240 $412 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $65.5 Million - $75.7 Million	-436,400 Reduced 14.08%	2,662,650 $438 Million
Q4 2020 Feb 10, 2021	SELL	$140.71 - $165.05 $33.2 Million - $38.9 Million	-235,900 Reduced 7.07%	3,099,050 $511 Million
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $15.1 Million - $20.6 Million	-143,263 Reduced 4.12%	3,334,950 $476 Million
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $3.79 Million - $4.83 Million	39,663 Added 1.15%	3,478,213 $384 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $9.72 Million - $16.9 Million	-110,821 Reduced 3.12%	3,438,550 $343 Million
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $50.8 Million - $66.4 Million	431,670 Added 13.85%	3,549,371 $530 Million
Q3 2019 Nov 13, 2019	BUY	$125.18 - $143.24 $70.3 Million - $80.5 Million	561,900 Added 21.99%	3,117,701 $400 Million
Q2 2019 Aug 12, 2019	BUY	$125.55 - $144.48 $70.6 Million - $81.3 Million	562,700 Added 28.23%	2,555,801 $364 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $103 Million - $120 Million	842,900 Added 73.28%	1,993,101 $285 Million
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $133 Million - $192 Million	1,150,201 New	1,150,201 $143 Million

Others Institutions Holding JAZZ

# of Institutions

584

Shares Held

60.4M

Call Options Held

424K

Put Options Held

192K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.1B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account